These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8587160)

  • 1. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
    Brown SA; Deleeuw NR; Stahl GL; Roof RD
    J Vet Pharmacol Ther; 1995 Oct; 18(5):385-7. PubMed ID: 8587160
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum.
    Clark C; Woodbury M; Dowling P; Ross S; Boison JO
    J Vet Pharmacol Ther; 2004 Oct; 27(5):385-7. PubMed ID: 15500580
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of tilmicosin in equine tissues and plasma.
    Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
    J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of administering long-acting oxytetracycline and tilmicosin either by dart gun or by hand on injection site lesions and drug residues in beef cattle.
    Van Donkersgoed J; VanderKop M; Salisbury C; Sears L; Holowath J
    Can Vet J; 1999 Aug; 40(8):583-7. PubMed ID: 12001341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep.
    Naccari F; Giofrè F; Pellegrino M; Calò M; Licata P; Carli S
    Vet Rec; 2001 Jun; 148(25):773-6. PubMed ID: 11465263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tilmicosin in serum and milk of goats.
    Ramadan A
    Res Vet Sci; 1997; 62(1):48-50. PubMed ID: 9160424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.
    Avci T; Elmas M
    ScientificWorldJournal; 2014; 2014():869096. PubMed ID: 25177733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of tilmicosin in lactating ewes.
    Atef M; Abo el-Sooud K; Nahed E; Tawfik M
    Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.
    Owens WE; Nickerson SC; Ray CH
    J Dairy Sci; 1999 Mar; 82(3):645-7. PubMed ID: 10194686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
    Lombardi KR; Portillo T; Hassfurther R; Hunter RP
    J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and intrapulmonary disposition of tilmicosin after single and repeated oral bolus administrations to rabbits.
    Gallina G; Lucatello L; Drigo I; Cocchi M; Scandurra S; Agnoletti F; Montesissa C
    Vet Res Commun; 2010 Jun; 34 Suppl 1():S69-72. PubMed ID: 20480234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilmicosin antibacterial activity and pharmacokinetics in cows.
    Ziv G; Shem-Tov M; Glickman A; Winkler M; Saran A
    J Vet Pharmacol Ther; 1995 Oct; 18(5):340-5. PubMed ID: 8587151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.
    Modric S; Webb AI; Davidson M
    Lab Anim Sci; 1999 Jun; 49(3):248-53. PubMed ID: 10403438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose determination and confirmation for ceftiofur crystalline-free acid administered in the posterior aspect of the ear for control and treatment of bovine respiratory disease.
    Hibbard B; Robb EJ; Chester ST; Dame KJ; Moseley WW; Bryson WL
    Vet Ther; 2002; 3(1):22-30. PubMed ID: 12050825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of direct sampling and brochoalveolar lavage for determining active drug concentrations in the pulmonary epithelial lining fluid of calves injected with enrofloxacin or tilmicosin.
    Foster DM; Sylvester HJ; Papich MG
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e45-e53. PubMed ID: 28457009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells.
    Scorneaux B; Shryock TR
    J Dairy Sci; 1999 Jun; 82(6):1202-12. PubMed ID: 10386306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of haematological and biochemical side effects of tilmicosin in healthy New Zealand rabbits.
    Altunok V; Yazar E; Elmas M; Traş B; Baş AL; Cöl R
    J Vet Med B Infect Dis Vet Public Health; 2002 Mar; 49(2):68-70. PubMed ID: 12002421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
    Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
    J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses.
    Cox KS; Nelson BB; Wittenburg L; Gold JR
    Equine Vet J; 2017 May; 49(3):341-344. PubMed ID: 27458113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in residue concentrations of tilmicosin in cattle muscle.
    Beechinor JG; Bloomfield FJ
    Vet Rec; 2001 Aug; 149(6):182-3. PubMed ID: 11530904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.